These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents. Silveira MG; Lindor KD Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of primary biliary cirrhosis. Ali AH; Carey EJ; Lindor KD Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237 [TBL] [Abstract][Full Text] [Related]
5. The timing of liver transplantation in primary biliary cirrhosis. Angulo P; Dickson ER Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):657-68. PubMed ID: 10976021 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of cholestatic liver diseases with ursodeoxycholic acid]. Boberg KM; Schrumpf E Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890 [TBL] [Abstract][Full Text] [Related]
7. Recurrent primary biliary cirrhosis after liver transplantation--the disease and its management. Schreibman I; Regev A MedGenMed; 2006 May; 8(2):30. PubMed ID: 16926769 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of cholestatic liver disease]. Pleşa A Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010 [TBL] [Abstract][Full Text] [Related]
9. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection? Hay JE Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489 [TBL] [Abstract][Full Text] [Related]
10. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401 [TBL] [Abstract][Full Text] [Related]
11. Primary biliary cirrhosis in the era of liver transplantation. Raczyńska J; Habior A; Pączek L; Foroncewicz B; Pawełas A; Mucha K Ann Transplant; 2014 Sep; 19():488-93. PubMed ID: 25262831 [TBL] [Abstract][Full Text] [Related]
12. Primary biliary cirrhosis and bile acids. Corpechot C Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S13-20. PubMed ID: 23141888 [TBL] [Abstract][Full Text] [Related]
13. Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win? Benner KG Liver Transpl Surg; 1999 Jul; 5(4):334-7. PubMed ID: 10388507 [No Abstract] [Full Text] [Related]
15. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy. Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236 [TBL] [Abstract][Full Text] [Related]
16. How, why, and when does primary biliary cirrhosis recur after liver transplantation? Williams R; Gershwin ME Liver Transpl; 2007 Sep; 13(9):1214-6. PubMed ID: 17763403 [No Abstract] [Full Text] [Related]
17. [The influence of ursodeoxycholic acid on some biochemical, immunologic and histopathologic parameters in patients with primary biliary cirrhosis]. Skulina D; Owczarek D; Ciećko-Michalska I; Szczepański W; Tetnowski J; Garlicka M; Janas-Skulina U Przegl Lek; 1999; 56(3):201-4. PubMed ID: 10442009 [TBL] [Abstract][Full Text] [Related]